Literature DB >> 2347126

Limb leads of the electrocardiogram: sequencing revisited.

G E Dower1, S B Nazzal, O Pahlm, W K Haistey, H L Marriott, R H Bullington, D Bullington.   

Abstract

The six limb leads are normally presented in a format the logic of which is traditional rather than anatomical and does not allow visual interpolation such as is customary with the six chest leads. The sequence: a VL, I, -aVR, II, aVF, III was suggested years ago, and is used in some European countries, particularly Sweden. It provides a better impression of the extent of the changes of inferior infarction and makes the rather neglected lead aVR much more useful, though reversed in polarity. It also provides a more direct indication of the electrical axis, and simplifies comparisons with the frontal plane vectorcardiogram. Because modern digital electrocardiographs can provide the sequenced format, this seems a good time to review the advantages of adopting it.

Entities:  

Mesh:

Year:  1990        PMID: 2347126     DOI: 10.1002/clc.4960130508

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  3 in total

1.  Improving the ECG classification of inferior and lateral myocardial infarction by inversion of lead aVR.

Authors:  I B Menown; A A Adgey
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

2.  Why complicate an important task? An orderly display of the limb leads in the 12-lead electrocardiogram and its implications for recognition of acute coronary syndrome.

Authors:  T Lindow; Y Birnbaum; K Nikus; A Maan; U Ekelund; O Pahlm
Journal:  BMC Cardiovasc Disord       Date:  2019-01-10       Impact factor: 2.298

3.  Subepicardial burn injuries in bullfrog heart induce electrocardiogram changes mimicking inferior wall myocardial infarction.

Authors:  Itsuro Kazama; Ryo Kuwana; Mizuki Muto; Amu Nagano; Ririka Fujimura; Ayano Asada; Tsutomu Tamada; Makoto Shimoyama
Journal:  J Vet Med Sci       Date:  2022-07-08       Impact factor: 1.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.